IP Library › Granted Patent US 11,785,973
Granted Patent B2
US 11,785,973 · App. 17/003,099 · Granted Oct 17, 2023

Capsule clusters for oral consumption

Inventors: Danielle R. Crawford (Chester, VA); Shon Gedevani (Richmond, VA); William R. Sweeney (Richmond, VA); Chris Irving (Richmond, VA)
Assignee: Philip Morris USA Inc.
A23L27/72A23L29/212A23L29/25A23L29/256A23L33/15A23P10/30A23P30/10A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,785,973
App. No.
17/003,099
Granted
Oct 17, 2023
Kind
B2
Abstract

An oral product includes a matrix including a mixture of a plurality of capsules, a powdered component, a viscous component and a binder and wherein the matrix is molded into a shape. In a preferred embodiment, the capsules provide functional and flavorful ingredients. In an embodiment, the matrix is enclosed in a porous material that forms a pouch.

Claims (29)

1. An oral product configured to fit comfortably in a user's mouth, the oral product comprising:

a matrix including,

a plurality of capsules, each of the capsules of the plurality of capsules having a shell thickness of 0.1 mm to 7 mm; and

a binder including sodium alginate, sugar, agar, guar gum, flour, water, maltodextrin, a viscous substance, or any combination thereof,

the matrix including 10% to 60% of the binder by weight of the oral product, and the matrix being molded and proportioned.

2. The oral product of claim 1 , wherein the plurality of capsules include:

a plurality of functional capsules, a plurality of flavor capsules, or both a plurality of functional capsules and a plurality of flavor capsules.

3. The oral product of claim 2 , wherein each of the plurality of capsules has an average size of 8 mm to 14 mm.

4. The oral product of claim 2 , wherein the plurality of functional capsules includes a chemesthesis agent, an antioxidant, a vitamin, a soothing agent, an energizing agent, an alerting agent, a calming agent, or any combination thereof.

5. The oral product of claim 4 , wherein

the soothing agent comprises chamomile, lavender, jasmine, or any combination thereof;

the energizing agent comprises caffeine, taurine, guarana, vitamin B6, vitamin B12, or any combination thereof; and

the chemesthesis agent comprises mint, menthol, capsaicin, cinnamon, pepper, or any combination thereof.

6. The oral product of claim 2 , wherein the plurality of flavor capsules include pomegranate, acai, raspberry, blueberry, strawberry, cranberry, menthol, peppermint, spearmint, bourbon, scotch, whiskey, cognac, hydrangea, lavender, chocolate, licorice, citrus, apple, peach, pear, cherry, plum, orange, grapefruit, gamma octalactone, vanillin, ethyl vanillin, cinnamon, clove, nutmeg, sage, anise, fennel, methyl salicylate, linalool, jasmine, coffee, bergamot oil, geranium oil, lemon oil, ginger oil, tea herb, tea extracts, or any combination thereof.

7. The oral product of claim 1 , wherein the plurality of capsules include an effervescent agent.

8. The oral product of claim 7 , wherein the effervescent agent includes gases, baking soda, citric acid, or any combination thereof.

9. The oral product of claim 1 , wherein the matrix further comprises 10% to 40% of a powdered component by weight of the oral product.

10. The oral product of claim 9 , wherein the powdered component includes dry sour cream, baking soda, powdered sugar, powdered cocoa, powdered spices, powdered herbs, tea, tea extracts, guarana, or any combination thereof.

11. The oral product of claim 1 , wherein the viscous substance includes honey, molasses, syrups, or any combination thereof.

12. The oral product of claim 1 , wherein the binder has a water activity greater than or equal to 0.4 aw to less than or equal to 0.8 aw.

13. The oral product of claim 1 , wherein

the matrix is encapsulated by a membrane coating, and

the membrane coating is a single layer, bicomponent coating that includes a soluble, non-cross-linked component and an insoluble, cross-linked component.

14. The oral product of claim 13 , wherein the soluble, non-cross-linked component includes a non-cross-linkable polymer including starch, dextrin, gum arabic, guar gum, chitosan, cellulose, polyvinyl alcohol, polylactide, soy protein, whey protein, or any combination thereof.

15. The oral product of claim 14 , wherein the insoluble, cross-linked component includes a chemically cross-linkable polymer including one or more modified polysaccharides with cross-linkable functional groups.

16. The oral product of claim 1 , wherein the oral product includes a pouch and the matrix is disposed within the pouch.

17. The oral product of claim 16 , wherein the pouch includes a porous material.

18. The oral product of claim 16 , wherein the oral product weighs 0.2 g to 5.0 g and has dimensions of less than or equal to about 25 mm.

19. The oral product of claim 1 , wherein the pouch has a crescent shape, a half-moon shape, a rhombus shape, a trapezoid shape, an ellipsis shape, a rectangle shape, a heart shape, a square shape, or an oval shape.

Continuity (6)
Continuation 15971160 · May 4, 2018
Continuation 15425601 · Feb 6, 2017
Continuation 14573524 · Dec 17, 2014
Division 12155634 · Jun 6, 2008
Provisional Application 60929028 · Jun 8, 2007
Related Publication 20200383366A1 · Dec 10, 2020